The ferric-hydroperoxo complex of chloroperoxidase

Biochemical and Biophysical Research Communications

Volumn 363, Issue 4, 2007, Pages 954-958

  Denisov, Ilia G ^a   Dawson, John H ^b   Hager, Lowell P ^a   Sligar, Stephen G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chloroperoxidase; Cryogenic spectroscopy; Cytochrome P450; Heme enzyme; Peroxo ferric intermediate; Radiolytic reduction

Indexed keywords

CATALASE; CHLORIDE PEROXIDASE; CYTOCHROME P450; CYTOCHROME P450 CYP101; FERRIC HYDROXIDE; HEME OXYGENASE; NITRIC OXIDE SYNTHASE; PEROXIDASE; PEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; COMPLEX FORMATION; IRRADIATION; PH MEASUREMENT; PRIORITY JOURNAL; SPECTROSCOPY; X RAY ANALYSIS;

CHLORIDE PEROXIDASE; IRON; PEROXIDES; PROTEIN BINDING; SPECTROPHOTOMETRY;

EID: 35048837047     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.09.085     Document Type: Article

References (46)

1. Sligar S.G., Makris T.M., and Denisov I.G. Thirty years of microbial P450 monooxygenase research: peroxo-heme intermediates-the central bus station in heme oxygenase catalysis. Biochem. Biophys. Res. Commun. 338 (2005) 346-354
2. Egawa T., Yoshioka S., Takahashi S., Hori H., Nagano S., Shimada H., Ishimori K., Morishima I., Suematsu M., and Ishimura Y. Kinetic and spectroscopic characterization of a hydroperoxy compound in the reaction of native myoglobin with hydrogen peroxide. J. Biol. Chem. 278 (2003) 41597-41606
3. Shintaku M., Matsuura K., Yoshioka S., Takahashi S., Ishimori K., and Morishima I. Absence of a detectable intermediate in the compound I formation of horseradish peroxidase at ambient temperature. J. Biol. Chem. 280 (2005) 40934-40938
4. Denisov I.G., Makris T.M., and Sligar S.G. Cryoradiolysis for the study of P450 reaction intermediates. Methods Enzymol. 357 (2002) 103-115
5. Makris T.M., Davydov R., Denisov I.G., Hoffman B.M., and Sligar S.G. Mechanistic enzymology of oxygen activation by the cytochromes P450. Drug Metab. Rev. 34 (2002) 691-708
6. Kuhnel K., Derat E., Terner J., Shaik S., and Schlichting I. Structure and quantum chemical characterization of chloroperoxidase compound 0, a common reaction intermediate of diverse heme enzymes. Proc. Natl. Acad. Sci. USA 104 (2007) 99-104
7. Symons M.C.R., and Petersen R.L. Electron capture at the iron-oxygen centre in single crystals of oxymyoglobin studied by electron spin resonance spectroscopy. Biochim. Biophys. Acta 535 (1978) 241-247
8. - (ferrite) center from irradiated oxyhemo- and oxymyoglobin. Biochim. Biophys. Acta 827 (1985) 327-343
9. Davydov R.M. Optical and ESR-spectroscopic study of electronic adducts of oxymyoglobin and oxyhemoglobin. Biofizika 25 (1980) 203-207
10. Davydov R.M., and Ledenev A.N. Activation mechanism of molecular oxygen with cytochrome P-450. Biofizika 26 (1981) 1096
11. Davydov R., Kappl R., Huttermann J., and Peterson J.A. EPR-spectroscopy of reduced oxyferrous-P450cam. FEBS Lett. 295 (1991) 113-115
12. Davydov R., Makris T.M., Kofman V., Werst D.E., Sligar S.G., and Hoffman B.M. Hydroxylation of camphor by reduced oxy-cytochrome P450cam: mechanistic implications of EPR and ENDOR studies of catalytic intermediates in native and mutant enzymes. J. Am. Chem. Soc. 123 (2001) 1403-1415
13. Davydov R., Ledbetter-Rogers A., Martasek P., Larukhin M., Sono M., Dawson J.H., Masters B.S., and Hoffman B.M. EPR and ENDOR characterization of intermediates in the cryoreduced oxy-nitric oxide synthase heme domain with bound L-arginine or N(G)-hydroxyarginine. Biochemistry 41 (2002) 10375-10381
14. Davydov R., Kofman V., Fujii H., Yoshida T., Ikeda-Saito M., and Hoffman B.M. Catalytic mechanism of heme oxygenase through EPR and ENDOR of cryoreduced oxy-heme oxygenase and its Asp 140 mutants. J. Am. Chem. Soc. 124 (2002) 1798-1808
15. Denisov I.G., Makris T.M., and Sligar S.G. Formation and decay of hydroperoxo-ferric heme complex in horseradish peroxidase studied by cryoradiolysis. J. Biol. Chem. 277 (2002) 42706-42710
16. Davydov R., Kofman V., Nocek J.M., Noble R.W., Hui H., and Hoffman B.M. Conformational substates of the oxyheme centers in alpha and beta subunits of hemoglobin as disclosed by EPR and ENDOR studies of cryoreduced protein. Biochemistry 43 (2004) 6330-6338
17. Davydov R., Chemerisov S., Werst D.E., Rajh T., Matsui T., Ikeda-Saito M., and Hoffman B.M. Proton transfer at helium temperatures during dioxygen activation by heme monooxygenases. J. Am. Chem. Soc. 126 (2004) 15960-15961
18. Denisov I.G., Makris T.M., and Sligar S.G. Cryotrapped reaction intermediates of cytochrome p450 studied by radiolytic reduction with phosphorus-32. J. Biol. Chem. 276 (2001) 11648-11652
19. Denisov I.G., Ikeda-Saito M., Yoshida T., and Sligar S.G. Cryogenic absorption spectra of hydroperoxo-ferric heme oxygenase, the active intermediate of enzymatic heme oxygenation. FEBS Lett. 532 (2002) 203-206
20. Ibrahim M., Denisov I.G., Makris T.M., Kincaid J.R., and Sligar S.G. Resonance Raman spectroscopic studies of hydroperoxo-myoglobin at cryogenic temperatures. J. Am. Chem. Soc. 125 (2003) 13714-13718
21. Mak P.J., Denisov I.G., Victoria D., Makris T.M., Deng T., Sligar S.G., and Kincaid J.R. Resonance Raman detection of the hydroperoxo intermediate in the cytochrome P450 enzymatic cycle. J. Am. Chem. Soc. 129 (2007) 6382-6383
22. Makris T.M., Denisov I.G., and Sligar S.G. Haem-oxygen reactive intermediates: catalysis by the two-step. Biochem. Soc. Trans. 31 (2003) 516-519
23. Makris T.M., Denisov I.G., Schlichting I., and Sligar S.G. Activation of molecular oxygen by cytochrome P450. In: Ortiz-de-Montellano P.R. (Ed). Cytochrome P450: Structure, Function, Genetics (2005), Kluwer Academic/Plenum Publishers, New York 149-182
24. Denisov I.G., Makris T.M., Sligar S.G., and Schlichting I. Structure and chemistry of cytochrome P450. Chem. Rev. 105 (2005) 2253-2277
25. Ibrahim M., and Kincaid J.R. Spectroscopic studies of peroxo/hydroperoxo derivatives of heme proteins and model compounds. J. Porphyr. Phthalocya. 8 (2004) 215-225
26. Cooper C.E., Jurd M., Nicholls P., Wankasi M.M., Svistunenko D.A., Reeder B.J., and Wilson M.T. On the formation, nature, stability and biological relevance of the primary reaction intermediates of myoglobins with hydrogen peroxide. Dalton Trans. (2005) 3483-3488
27. Ichikawa Y., Nakajima H., and Watanabe Y. Characterization of peroxide-bound heme species generated in the reaction of thermally tolerant cytochrome c552 with hydrogen peroxide. Chembiochem 7 (2006) 1582-1589
28. Svistunenko D.A., Reeder B.J., Wankasi M.M., Silaghi-Dumitrescu R.-L., Cooper C.E., Rinaldo S., Cutruzzola F., and Wilson M.T. Reaction of Aplysia limacina metmyoglobin with hydrogen peroxide. Dalton Trans. (2007) 840-850
29. Watanabe Y., Nakajima H., and Ueno T. Reactivities of oxo and peroxo intermediates studied by hemoprotein mutants. Acc. Chem. Res. 40 (2007) 554-562
30. Lambeir A.M., and Dunford H.B. Oxygen binding to dithionite-reduced chloroperoxidase. Eur. J. Biochem. 147 (1985) 93-96
31. Sono M., Eble K.S., Dawson J.H., and Hager L.P. Preparation and properties of ferrous chloroperoxidase complexes with dioxygen, nitric oxide, and an alkyl isocyanide. Spectroscopic dissimilarities between the oxygenated forms of chloroperoxidase and cytochrome P-450. J. Biol. Chem. 260 (1985) 15530-15535
32. Hollenberg P.F., and Hager L.P. Purification of chloroperoxidase from Caldariomyces fumago. Methods Enzymol. 52 (1978) 521-529
33. Denisov I.G., Victoria D.C., and Sligar S.G. Cryoradiolytic reduction of heme proteins: maximizing dose-dependent yield. Radiat. Phys. Chem. 76 (2007) 714-721
34. Hollenberg P.F., Hager L.P., Blumberg W.E., and Peisach J. An electron paramagnetic resonance study of the high and low spin forms of chloroperoxidase. J. Biol. Chem. 255 (1980) 4801-4807
35. Lambeir A.M., and Dunford H.B. A kinetic and spectral study of the alkaline transitions of chloroperoxidase. Arch. Biochem. Biophys. 220 (1983) 549-556
36. Kuhnel K., Blankenfeldt W., Terner J., and Schlichting I. Crystal structures of chloroperoxidase with its bound substrates and complexed with formate, acetate, and nitrate. J. Biol. Chem. 281 (2006) 23990-23998
37. Hanson L.K., Sligar S.G., and Gunsalus I.C. Electronic structure of cytochrome P450. Croat. Chem. Acta 49 (1977) 237-250
38. Hanson L.K., Eaton W.A., Sligar S.G., Gunsalus I.C., Gouterman M., and Connell C.R. Origin of the anomalous Soret spectra of carboxycytochrome P-450. J. Am. Chem. Soc. 98 (1976) 2672-2674
39. Harris D., Loew G., and Waskell L. Structure and spectra of ferrous dioxygen and reduced ferrous dioxygen model cytochrome P450. J. Am. Chem. Soc. 120 (1998) 4308-4318
40. Loew G. Electronic structure of heme sites. In: Solomon E.I., and Lever A.B.P. (Eds). Inorganic Electronic Structure and Spectroscopy (1999), John Wiley & Sons, New York 451-531
41. Loew G. Structure, spectra, and function of heme sites. Int. J. Quant. Chem. 77 (2000) 54-70
42. Denisov I.G., Hung S.C., Weiss K.E., McLean M.A., Shiro Y., Park S.Y., Champion P.M., and Sligar S.G. Characterization of the oxygenated intermediate of the thermophilic cytochrome P450 CYP119. J. Inorg. Biochem. 87 (2001) 215-226
43. Glascock M.C., Ballou D.P., and Dawson J.H. Direct observation of a novel perturbed oxyferrous catalytic intermediate during reduced putidaredoxin-initiated turnover of cytochrome P-450-CAM: probing the effector role of putidaredoxin in catalysis. J. Biol. Chem. 280 (2005) 42134-42141
44. Dawson J.H., Andersson L.A., Sono M., and Hager L.P. Systematic trends in the spectroscopic properties of low-spin ferric ligand adducts of cytochrome P-450 and chloroperoxidase: the transition from normal to hyper spectra. New J. Chem. 16 (1992) 577-582
45. Roach M.P., Pond A.E., Thomas M.R., Boxer S.G., and Dawson J.H. The role of the distal and proximal protein environments in controlling the ferric spin state and in stabilizing thiolate ligation in heme systems: thiolate adducts of the myoglobin H93G cavity mutant. J. Am. Chem. Soc. 121 (1999) 12088-12093
46. Hoffman B.M. ENDOR of metalloenzymes. Acc. Chem. Res. 36 (2003) 522-529